Koyfin Home > Directory > Health Care > Aduro Biotech > Cash Acquisitions

Aduro Biotech Cash Acquisitions Chart (ADRO)

Aduro Biotech annual/quarterly Cash Acquisitions from 2015 to 2015.
  • Aduro Biotech Cash Acquisitions for the quarter ending December 12, 2015 was $-14m
  • Aduro Biotech Cash Acquisitions for the last 12 months ending September 09, 2016 was $-14m a 0.00% decrease of 0m year over year
Other Cash Flow Metrics:
  • Aduro Biotech Cash Flow from Operations for the quarter ending December 12, 2018 was $-1m a -1,784.81% increase of 20m year over year
  • Aduro Biotech Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-23m a 36.84% decrease of -8m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO Cash Acquisitions Data

12/2015$-14m

Annual ADRO Cash Acquisitions Data

2015$-14m